SHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, increasing competition with…
Stay informed with our crypto and finance news site. Get the latest updates on digital assets, market trends, and financial news to make informed decisions and stay ahead in the world of finance.